Literature DB >> 7651992

The effect of hyperthermia-induced tissue conductivity changes on electrical impedance temperature mapping.

M A Esrick1, D A McRae.   

Abstract

Changes in tissue electrical conductivity in the low radiofrequency range due to tissue temperature coefficients (TCS), approximately 2% degrees C-1, have been investigated by others as a non-invasive means of determining tissue temperature changes during the application of therapeutic hyperthermia. However, the occurrence of additional changes in conductivity due to non-TC effects, for example, from heat-induced oedema, or changes in cellular volume or membrane characteristics, can result in incorrect temperature determination based solely on the TC. This paper (i) presents estimates of the errors that will occur in temperature mapping using electrical impedance measurements if non-TC effects are ignored, using examples of excised and in vivo EMT6 tumours, (ii) presents a method of differentiating the onset of non-TC effects from TC effects using conductance measurements, thereby allowing for use of the TC method until the onset of non-TC effects, and (iii) suggests a means of using conductance measurements to monitor the course of hyperthermia treatments, without the use of temperature information, based on hyperthermia-induced cellular changes.

Entities:  

Mesh:

Year:  1994        PMID: 7651992     DOI: 10.1088/0031-9155/39/1/008

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  2 in total

1.  Hepatic radiofrequency ablation at low frequencies preferentially heats tumour tissue.

Authors:  Dieter Haemmerich; Bradford J Wood
Journal:  Int J Hyperthermia       Date:  2006-11       Impact factor: 3.914

Review 2.  Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment.

Authors:  Adela Ademaj; Danai P Veltsista; Pirus Ghadjar; Dietmar Marder; Eva Oberacker; Oliver J Ott; Peter Wust; Emsad Puric; Roger A Hälg; Susanne Rogers; Stephan Bodis; Rainer Fietkau; Hans Crezee; Oliver Riesterer
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.